Company intelligence / Profile preview

Heka VR

Copenhagen, Denmark

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Clinical trial results published in The Lancet Psychiatry (July 2025) show VR-based Avatar Therapy effective for 7/10 patients with treatment-resistant schizophrenia, reducing auditory hallucinations. Involved in 10+ clinical trials globally.[1][2][4]

Therapeutic areas: Psychiatry
Modalities: Device
Industry: Digital Health Medical Devices

Partnerships

VIRTU Research Group (Gentofte Hospital)Region HovedstadenRegion SyddanmarkRegion Nord (Denmark)Khora Virtual Reality (spin-off from)

Beyond the preview

Go deeper on Heka VR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heka VR.

Explore the full profile